About Us
|
contact Us
|
Sitemap
Call us: +1-855-455-8662
|
Home
Business Solutions
Business Research Reports
Business Consulting
On-site Implementation & Training Programs
Industry Trackers
Subscription Solutions
Industry Reports
News
Press
Login
Register
Home
Drugs by Therapeutic Area
Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Expected CAGR 9.8% by 2032
Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market By Infection (Cellulitis, Abscess, Surgical Wounds, & Traumatic Wound), By Type Of Drug (Delafloxacin, Vancomycin, Ceftaroline Fosamil, Telvancin & Others), By Pathogens (MSSA, MRSA, Beta-Hemolytic Streptococcus, Escherichia Coli & Others) - Growth, Future Prospects, And Competitive Analysis, 2025 -2033
20 Aug 2017
Format
Request Sample
Report Summary
Table of contents
list of tables
list of figures
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market
2.2. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Drug, 2024 (US$ Million)
2.3. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Infection, 2024 (US$ Million)
2.4. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Pathogen, 2024 (US$ Million)
2.5. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, By Geography, 2024 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2024
3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Vendors
3.2. Strategies Adopted by Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Vendors
4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market Value, 2023 - 2033, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Technology Landscape
4.6.4. Legal Landscape
4.6.5. Social Landscape
5. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2024 Versus 2033
5.3. Market Segmentation
5.3.1. Delafloxacin
5.3.2. Vancomycin
5.3.3. Ceftaroline fosamil
5.3.4. Telvancin
5.3.5. Oritavancin
5.3.6. Tedizolid
5.3.7. Daptomycin
5.3.8. Tigecycline
5.3.9. Linezolid
5.3.10. TMP-SMZ
5.3.11. Others (Doxycycline, Levofloxacin, Metronidazole, and Others)
6. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2024 Versus 2033
6.3. Market Segmentation
6.3.1. Cellulitis
6.3.2. Abscess/Boil/Cyst
6.3.3. Surgical Wound
6.3.4. Traumatic Wound
7. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2024 Versus 2033
7.3. Market Segmentation
7.3.1. Methicillin sensitive Staphylococcus aureus (MSSA)
7.3.2. Methicillin resistant Staphylococcus aureus (MRSA)
7.3.3. Beta-hemolytic Streptococcus
7.3.4. Escherichia coli
7.3.5. Enterococcus faecalis
7.3.6. Pseudomonas aeruginosa
7.3.7. Others
8. North America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2023-2033, USD (Million)
8.1. Market Overview
8.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
8.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
8.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
8.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2023-2033, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
8.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
8.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
8.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
8.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
8.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
8.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
9. UK and European Union Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2023-2033, USD (Million)
9.1. Market Overview
9.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
9.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
9.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
9.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2023-2033, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
9.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
9.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
9.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
9.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
9.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
9.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
9.5.1.4.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
9.5.1.4.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
9.5.1.5. France
9.5.1.5.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
9.5.1.5.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
9.5.1.5.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
9.5.1.6.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
9.5.1.6.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
10. Asia Pacific Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2023-2033, USD (Million)
10.1. Market Overview
10.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
10.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
10.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
10.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2023-2033, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
10.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
10.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
10.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
10.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
10.5.1.3. India
10.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
10.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
10.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
10.5.1.4.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
10.5.1.4.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
10.5.1.5.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
10.5.1.5.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
10.5.1.6.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
10.5.1.6.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
11. Latin America Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2023-2033, USD (Million)
11.1. Market Overview
11.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
11.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
11.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
11.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2023-2033, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
11.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
11.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
11.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
11.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
11.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
11.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
12. Middle East and Africa Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market, 2023-2033, USD (Million)
12.1. Market Overview
12.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
12.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
12.4. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
12.5.Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Region, 2023-2033, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
12.5.1.1.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
12.5.1.1.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
12.5.1.2.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
12.5.1.2.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Drug, 2023-2033, USD (Million)
12.5.1.3.2. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Infection, 2023-2033, USD (Million)
12.5.1.3.3. Acute Bacterial Skin And Skin Structure Infections (ABSSSI) Treatment Market: By Pathogen, 2023-2033, USD (Million)
13. Company Profile
13.1. Furiex Pharmaceuticals, Inc.
(Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
13.2. GlaxoSmithKline plc
13.3. Melinta Therapeutics, Inc.
13.4. Debiopharm International S.A.
13.5. MerLion Pharmaceuticals Pte Ltd.
13.6. Durata Therapeutics, Inc.
13.7. Paratek Pharmaceuticals, Inc.
13.8. Cempra, Inc.
13.9. Abbott Laboratories, Inc.
13.10. Actelion Pharmaceuticals Ltd.
13.11. Albany Molecular Research, Inc.
13.12. Allergan plc.
13.13. AstraZeneca
13.14. Bayer AG
13.15. Macrolide Pharmaceuticals, Inc.
13.16. Merck & Co, Inc.
13.17. Pfizer, Inc.
13.18. Sanofi
13.19. Teva Pharmaceuticals Industries Ltd.
13.20. Zavante Therapeutics, Inc.
Choose Licence Type
Single User Licence
$4325
Multi User license
$6325
Corporate license
$12650
Buy Now
Quick Contact
+1-855-455-8662
+91 77559-81103
sales@acutemarketreports.com
View Other Reports
Automotive
986
Chemicals and Materials
684
Consumer Goods
184
Energy
124
Food & Beverages
321
Medical Devices
178
Pharmaceutical & Healthcare
78
Technology
234